Contract HHSF223201000030I
Biogx, Inc · Department Of Health And Human Services · June 3, 2010
Biogx, Inc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on June 3, 2010 for $989,000 of work in in-vitro diagnostic substance manufacturing. It was awarded under a small business set-aside. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 8, 2012.
Contract details
- PIID
- HHSF223201000030I
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- First action
- June 3, 2010
- Latest action
- June 8, 2012
Description
RAPID TEST KITS REAGENTS
Modification timeline
-
June 8, 2012Mod 2$335.8K
-
August 3, 2011Mod 1FUNDS-RAPID TEST KITS REAGENTS -- URGENT -- SHIPPING TO CFSAN LAUREL MD -- BIOGX 202-0004 FDA E COLI STEC EHEC SCR 1 CEPHEID SMART DISPENSER OF 80 REACTIONS$335.8K
-
June 3, 2010Base awardTAS::75 0600::TAS FUNDS-RAPID TEST KITS REAGENTS -- URGENT -- SHIPPING TO CFSAN LAUREL MD -- BIOGX 202-0004 FDA E COLI STEC EHEC SCR 1 CEPHEID SMART DISPENS$317.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSF223201000030I?
Contract HHSF223201000030I is a federal contract awarded to Biogx, Inc by Department Of Health And Human Services on June 3, 2010 for $989,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract HHSF223201000030I?
Biogx, Inc won contract HHSF223201000030I from Department Of Health And Human Services.
How much is contract HHSF223201000030I worth?
Contract HHSF223201000030I has obligated $989,000 to date.